{"nct_id":"NCT06915025","title":"Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-07-09","start_date_type":"ACTUAL","primary_completion_date":"2032-10-31","primary_completion_date_type":"ESTIMATED","completion_date":"2032-10-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["IMNN"]}